The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Subclinical pulmonary infiltrates/ILD
Publications
The effects of neoadjuvant chemotherapy on pulmonary structures: a quantitative analysis.
The Thoracic and cardiovascular surgeon 2012 Mar;60;111-5 — 2012 Mar — 111-5
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Anticancer research 2010 Oct;30;4381-7 — 2010 Oct — 4381-7
Yumuk PF, Kefeli U, Ceyhan B, Dane F, Eroglu BT, Gumus M, Cabuk D, Basaran G, Abacioglu U, Turhal NS
Pulmonary toxicity in patients receiving docetaxel chemotherapy.
Medical oncology (Northwood, London, England) 2010 Dec;27;1381-8 — 2010 Dec — 1381-8
Structural lung damage after chemotherapy fact or fiction?
Lung cancer (Amsterdam, Netherlands) 2010 Mar;67;306-10 — 2010 Mar — 306-10
The diagnostic significance of gallium lung uptake in patients with normal chest radiographs.
Radiology 1978 Apr;127;189-93 — 1978 Apr — 189-93